Guys I really can't express my joy with this study result!
For context - Renalytix's KidneyIntelX was USD$635M over a 5 year term.
PromarkerD $862M over 4 years significantly trumps KidneyIntelX.
Source: https://renalytixai.com/wp-content/uploads/2020/03/BHA-Renalytix-KidneyIntelX-NKF-Poster-3.25.20-FINAL-002.pdf
Also Note Richards comment here, no doubt he was specifically referring to KidneyIntelX which is $950 per test!
Something of interest is the KidneyIntelX economics study was developed by Boston Healthcare Associates, the same team that developed our study, and now they are co-presenting with Proteomics at this conference. Wow!
KidneyIntelX:
Source: https://investors.renalytixai.com/news-releases/news-release-details/renalytix-ai-plc-renalytixai-or-company-full-year-report
Shame the news got released today with a bit of market turmoil in the US, here's hoping investors take notice of this excellent opportunity.
Congrats guys, hold those shares tight!
Keep in mind, Renatlytix market cap = >$700M USD.
PIQ is a steal at these prices.
Ann: Major economic health benefit demonstrated for PromarkerD, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $60.56M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.0¢ | 36.0¢ | $16.01K | 43.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 18389 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 40172 | 1 |
View Market Depth
| Last trade - 11.29am 07/08/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |